Apex Science & Engineering Corp (3052) fair value: what the stock is really worth
As of Nov 9, 2026: fair value (intrinsic value) of Apex Science & Engineering Corp stock TWD 18.68, price TWD 10.40, upside +79.6%, quality 58 out of 100. Rating: strongly undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range 9.51 TWD – 14.25 TWD · fair‑value band 14.01 TWD – 23.36 TWD · the 10.40 TWD price screens below the 18.68 TWD fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 9, 2026.
Follow Apex Science & Engineering in your weekly email
Every Wednesday you see whether Apex Science & Engineering is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Apex Science & Engineering Corp. operates as an engineering and construction company in Taiwan. The company provides integrated engineering services, such as mechanical, electrical and instrumentation, and environmental engineering services.
Show moreShow less
It also manufactures optoelectronic and electrical products and offers customized LCD displays.
In addition, the company engages in commissioning construction companies to build residential and commercial buildings and develop professional industrial parks; civil engineering, construction, water conservancy, and other construction businesses; engineering consultants; and buying and selling engineering equipment and high-tech electronic products.
The company was formerly known as APEX Engineering Co., Ltd. and changed its name to Apex Science & Engineering Corp. in 2001. Apex Science & Engineering Corp. was founded in 1976 and is headquartered in New Taipei City, Taiwan.
Stock analysis
Apex Science & Engineering Corp (3052) currently trades at 10.40 TWD, while our model-based Fair Value estimate is 18.68 TWD, implying the stock looks roughly 44% undervalued today.
Show more
Valuation
Bull case: the Growth DCF group reads highest at a median of 82.28 TWD per share, and 20 of the 26 models we run sit above the 10.40 TWD price.
Bear case: the Dividend Discount group reads lowest at 6.05 TWD, and 6 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: 14.01 TWD (bear) to 23.36 TWD (bull), the price of 10.40 TWD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 58/100 (solid quality), in the Industrials sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Apex Science & Engineering Corp reported revenue of 3.4B TWD in FY2025 versus 3.6B TWD in FY2021, a compound −1.4%/yr. Reported net income was 224M TWD in FY2025, compounding +21.5%/yr from FY2021.
Key figures
Market cap 2.1B TWD (≈ $65.1M) Micro · P/E ratio 9.3 · P/S ratio 0.63 · EPS (TTM) 1.12 TWD · Dividend yield 5.8% · Net margin 6.7% · Return on equity 6.4% · Return on assets (EBIT) 2.4% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 35 out of 100 (low confidence).
What moves the price
The share trades about 15% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Industrials peers we cover trades at −42% fair-value upside, at 80%, 3052 screens cheaper than that median.
Fair Value models
Bear14.01 TWDFair Value 18.68 TWDBull23.36 TWD
Price 10.40 TWD · Upside +79.6%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Based on fiscal year 2025 figures (about 10 months old). Earnings retained since then (0.4459 TWD per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.82/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+10.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+4.9%
Dividend (yield on the price)5.8%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.4.9% vs 4.6%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.6% → 8%
Compare Apex Science & Engineering Corp with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Engineering & Construction · 791 stocks
Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score58 · Above median
Fair Value upside+79.6% · Top 25%
Profitability
Return on equity (12 months)6.4% · Below median
Return on assets1.7% · Below median
Net margin (12 months)6.7% · Above median
Operating margin (12 months)5.1% · Below median
Growth and dividend
Revenue growth (quarter YoY)−9.3% · Below median
Dividend yield (12 months)5.8% · Top 25%
Balance sheet
Debt / equity0.00× · Lowest 25%
Valuation Multiplesvs Engineering & Construction median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Apex Science & Engineering Corp (3052) overvalued or undervalued?
As of Nov 9, 2026, our model estimates a fair value of 18.68 TWD versus a price of 10.40 TWD, about +80% upside (undervalued).
What is the fair value of 3052?
Our model-based fair value for Apex Science & Engineering Corp is 18.68 TWD (as of Nov 9, 2026), built from audited fundamentals. The current price: 10.40 TWD.
What is the quality score of 3052?
Apex Science & Engineering Corp has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Apex Science & Engineering Corp (3052)?
Our model-based price target is the fair value of 18.68 TWD (as of Nov 9, 2026) from 26 valuation models. Cautious scenario 14.01 TWD, optimistic scenario 23.36 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the Apex Science & Engineering Corp stock forecast for 2026?
Our models put fair value at 18.68 TWD, about +80% upside versus a price of 10.40 TWD (undervalued). Cautious scenario 14.01 TWD, optimistic scenario 23.36 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of Apex Science & Engineering Corp (3052)?
Apex Science & Engineering Corp reported trailing-twelve-month revenue of about 3.4B TWD (latest available figure, as of Nov 9, 2026).
Does Apex Science & Engineering Corp pay a dividend?
Apex Science & Engineering Corp currently shows a dividend yield of 5.77% relative to its recent price (as of Nov 9, 2026).
How much is the dividend of Apex Science & Engineering Corp (3052) and when is the ex-dividend date?
Apex Science & Engineering Corp pays a dividend of 0.6 TWD per share a year, a dividend yield of 5.8%. The last ex-dividend date was Sep 1, 2026. The payout ratio is 53.6% of earnings. Free cash flow covers the dividend 14.66 times. Our assessment: Well covered. A low payout and the dividend is fully funded by free cash flow, a comfortable, sustainable dividend.
What is the intrinsic value of Apex Science & Engineering Corp (3052)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Apex Science & Engineering Corp it is 18.68 TWD per share (as of Nov 9, 2026), against a price of 10.40 TWD. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Apex Science & Engineering Corp stock overvalued or undervalued in 2026?
As of Nov 9, 2026, 3052 trades below its calculated fair value: price 10.40 TWD, fair value 18.68 TWD, a gap of about +80% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3052?
No. The price is what the market pays today (10.40 TWD); the fair value is what the company's own numbers justify (18.68 TWD). For Apex Science & Engineering Corp the two are 8.28 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is Apex Science & Engineering Corp worth?
The market values Apex Science & Engineering Corp at about 2.1B TWD (market capitalisation, as of Nov 9, 2026). Per share that is 10.40 TWD; our models calculate a fair value of 18.68 TWD per share.
What do the bullish and bearish scenarios say about 3052?
Our models span a range for Apex Science & Engineering Corp: cautious scenario 14.01 TWD, base 18.68 TWD, optimistic 23.36 TWD per share (as of Nov 9, 2026, price 10.40 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 3052?
Apex Science & Engineering Corp trades at a price-to-earnings ratio of 9.3 (as of Nov 9, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 18.68 TWD is built from several models across several years. Other multiples: P/B 0.6, P/S 0.6, EV/EBITDA 7.3.
How solid is the balance sheet of Apex Science & Engineering Corp (3052)?
Balance-sheet figures for Apex Science & Engineering Corp (as of Nov 9, 2026): return on equity 6.4%, debt of 0.00 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is 3052 from its 52-week high?
Apex Science & Engineering Corp trades at 10.40 TWD, about 15% below its 52-week high of 12.25 TWD and 2% above the low of 10.20 TWD (as of Nov 9, 2026). Distance from the high says nothing about value: that is what the fair value of 18.68 TWD is for.
Which stocks are comparable to Apex Science & Engineering Corp?
From the same area (Industrials) we also value Quanta Services, Inc, Vinci SA, Larsen & Toubro Limited, Comfort Systems USA, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Apex Science & Engineering Corp stock attractive at the current price?
The data as of Nov 9, 2026: price 10.40 TWD, calculated fair value 18.68 TWD (+80%), Quality Score 58/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3052 calculated?
We run Apex Science & Engineering Corp through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 18.68 TWD builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Apex Science & Engineering Corp currently trades 44% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Apex Science & Engineering Corp (3052)?
The closing price on Nov 9, 2026 was 10.40 TWD. Our model-based fair value is 18.68 TWD, about +80% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Apex Science & Engineering Corp right now?
The price is below even our cautious bear case (14.01 TWD). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (58/100) at a price below fair value, the discount is the argument here, not the business quality.
Where does the earnings growth of Apex Science & Engineering Corp (3052) come from?
Earnings per share at Apex Science & Engineering Corp grew +5.9 % a year from 2014 to 2025. Broken into its drivers: revenue per share +0.5 %, EBIT margin +4.7 %, tax rate −1.4 %, residual (interest, one-offs) +2.1 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.
Key figures of Apex Science & Engineering Corp
How large is the market capitalisation of Apex Science & Engineering Corp (3052)?
The market capitalisation of Apex Science & Engineering Corp is 2.1B TWD (≈ $65.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Apex Science & Engineering Corp (3052)?
The price-to-sales ratio of Apex Science & Engineering Corp is 0.63 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Apex Science & Engineering Corp (3052)?
Earnings per share at Apex Science & Engineering Corp are 1.12 TWD (price ÷ EPS = P/E 9.3). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Apex Science & Engineering Corp (3052)?
The dividend yield of Apex Science & Engineering Corp is 5.8% (payout 53.6%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Apex Science & Engineering Corp (3052)?
The net margin of Apex Science & Engineering Corp is 6.7% (last twelve months). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Apex Science & Engineering Corp (3052)?
The return on equity (ROE) of Apex Science & Engineering Corp is 6.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Apex Science & Engineering Corp (3052)?
On an EBIT basis the return on assets of Apex Science & Engineering Corp is 2.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Apex Science & Engineering Corp (3052)?
The operating margin of Apex Science & Engineering Corp is 5.1% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Apex Science & Engineering Corp (3052)?
Revenue at Apex Science & Engineering Corp is growing −9.3% versus a year earlier (3y avg +5.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Apex Science & Engineering Corp (3052)?
Earnings per share at Apex Science & Engineering Corp are growing +53.1% versus a year earlier. How much earnings per share grew versus a year earlier.
How much free cash flow does Apex Science & Engineering Corp (3052) generate?
The free cash flow of Apex Science & Engineering Corp is 1.8B TWD (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Apex Science & Engineering Corp (3052) carry?
The net debt of Apex Science & Engineering Corp is 2.1B TWD (fiscal year 2025, ≈ 1.2 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch Apex Science & Engineering Corp in the live analysis
One click puts Apex Science & Engineering Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 9, 2026